Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia

NCT00044889 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: clofarabine (IV formulation)

Sponsor

Genzyme, a Sanofi Company